In this final episode of Digital Therapeutics Edition, Eugene and his journalistic partner, Brian Dolan, reflect on the lessons learned, guest experts, and inspiring stories featured in season one. Brian is a journalist and the founder and lead writer of Exits & Outcomes, and in each episode, he asked the guests a pointed and challenging question about their digital solutions or their outlook on the DTx industry. 
It's been an eventful five months, Brian says -- companies have been bought, merged, and sold, and have raised impressive rounds of funding -- but there are other areas that have seen little progress since the podcast was launched.
There may be a season 2 of Digital Therapeutics Edition, but in the meantime, head over to healthxl.com/dtx to continue the conversation with Eugene and other experts.
What do you think the future of DTx will look like? 

>>Click here to read the transcript

Host Links and Resources:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Follow Eugene's journey of writing his first book: Hard Pill to Swallow


Connect with YourCoach.health: Website | Twitter


Subscribe to Exits & Outcomes


Brian Dolan: Twitter | LinkedIn


HealthXL: Website | Twitter | Join an Event



Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Cedars-Sinai Accelerator

Takeda

Roche